[Anti-thrombosis therapy following coronary stent implantation].
Coronary stenting has proved effective in the management of acute or imminent vessel closure after coronary balloon angioplasty. Stent implantation has also been shown to reduce the rate of restenosis. Opposing these benefits, subacute thrombotic stent occlusion is a serious and life-threatening complication which occurred at alarmingly high rates in early series. This paper reviews the contemporary strategies in the prevention of stent thrombosis, emphasizing improved procedural technique and optimal antiplatelet therapy. It is shown that these new preventive strategies led to acceptable subacute stent thrombosis rate of < or = 1%.
Schuiki
E
E
Departement Innere Medizin, Universitätsspital Zürich.
Facchini
M
M
Amann
F W
FW
D000925:Anticoagulants / Q000009:adverse effects / Q000627:therapeutic use*; D000075202:Contraindications; D003327:Coronary Disease / Q000601:surgery*; D006470:Hemorrhage / Q000139:chemically induced; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D011183:Postoperative Complications / Q000517:prevention & control; D015607:Stents / Q000009:adverse effects; D013927:Thrombosis / Q000209:etiology / Q000517:prevention & control*
D000925:Anticoagulants; D010975:Platelet Aggregation Inhibitors
Antithrombotische Therapie nach koronarer Stentimplantation.